Vir Biotechnology, Inc. Banner Image

Vir Biotechnology, Inc.

  • Ticker VIR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Vir Biotechnology, Inc. Logo Image
  • 201-500 Employees
  • Based in San Francisco, California
Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consistsMore of product candidates targeting hepatitis B virus, influenza A, SARS-CoV-2, human immunodeficiency virus and tuberculosis.
4.8 / 5.0 (207)

Vir Biotechnology, Inc. reports have an aggregate usefulness score of 4.8 based on 207 reviews.

Vir Biotechnology, Inc.

Most Recent Annual Report

Vir Biotechnology, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Vir Biotechnology, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!